Belén Sopesén Veramendi
Corporate Officer/Principal bei PHARMA MAR, S.A.
Profil
Belén Sopesén Veramendi is currently the Director-Virology Business Unit at Pharma Mar SA since 2021.
She is also currently a Director at Biocross SL.
Previously, she served as the Chief Executive Officer, MD & Director at Noscira SA from 2012 to 2014.
From 2015 to 2018, she was the GM, Director & Director-Market Research at Xylazel SA. Prior to that, she worked as the Technical Director & Manager at Ualysite Consultores SL from 2001 to 2005.
Dr. Sopesén Veramendi holds a doctorate degree from Universidad Complutense de Madrid, which she obtained in 1988.
Aktive Positionen von Belén Sopesén Veramendi
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMA MAR, S.A. | Corporate Officer/Principal | 01.01.2005 |
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Belén Sopesén Veramendi
| Unternehmen | Position | Ende |
|---|---|---|
Xylazel SA
 Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Vorstandsvorsitzender | 01.09.2018 |
Noscira SA
 Noscira SA Miscellaneous Commercial ServicesCommercial Services Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain | Vorstandsvorsitzender | 01.02.2014 |
| Ualysite Consultores SL | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Ausbildung von Belén Sopesén Veramendi
| Universidad Complutense de Madrid | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMA MAR, S.A. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Noscira SA
Noscira SA Miscellaneous Commercial ServicesCommercial Services Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain | Commercial Services |
Xylazel SA
Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Process Industries |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Health Technology |
| Ualysite Consultores SL |
